NCT04938869View on ClinicalTrials.gov

Continuous Glucose Monitor Application After Hospital Discharge for the Improvement of Outcomes in Patients With Poorly Controlled Type 2 Diabetes and Active Cancer

NACompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

October 5, 2021

Primary Completion Date

February 17, 2022

Study Completion Date

February 17, 2022

Conditions
Hematopoietic and Lymphoid System NeoplasmMalignant Solid NeoplasmType 2 Diabetes Mellitus
Interventions
OTHER

Educational Intervention

Receive basic diabetes mellitus education

OTHER

Medical Device Usage and Evaluation

Use CGM device and app

OTHER

Survey Administration

Ancillary studies

Trial Locations (1)

43210

Ohio State University Comprehensive Cancer Center, Columbus

All Listed Sponsors
lead

Ohio State University Comprehensive Cancer Center

OTHER

NCT04938869 - Continuous Glucose Monitor Application After Hospital Discharge for the Improvement of Outcomes in Patients With Poorly Controlled Type 2 Diabetes and Active Cancer | Biotech Hunter | Biotech Hunter